Answers are grounded in this paper and cite their sources.
The results of this study suggest that, in patients with moderate to severe symptoms, combination therapy of intense pulse light (IPL) and meibomian gland expression (MGX) could be a safe and useful approach for improving signs of dry eye disease (DED) due to meibomian gland dysfunction (MGD). Future studies are needed to elucidate if and how such improvements can be generalized to different severity levels of MGD.
No takes yet. Share an insight, caveat, or question.
Toyos et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: